0001638599-16-000693.txt : 20160229 0001638599-16-000693.hdr.sgml : 20160229 20160229172314 ACCESSION NUMBER: 0001638599-16-000693 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160225 FILED AS OF DATE: 20160229 DATE AS OF CHANGE: 20160229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 5600 BLAZER PARKWAY STREET 2: SUITE 200 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Regan William J. CENTRAL INDEX KEY: 0001559381 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35076 FILM NUMBER: 161469650 MAIL ADDRESS: STREET 1: NAVIDEA BIOPHARMACEUTICALS, INC. STREET 2: 425 METRO PLACE NORTH - SUITE 450 CITY: DUBLIN STATE: OH ZIP: 43017 4 1 doc4_3739.xml PRIMARY DOCUMENT X0306 4 2016-02-25 0 0000810509 NAVIDEA BIOPHARMACEUTICALS, INC. NAVB 0001559381 Regan William J. 5600 BLAZER PARKWAY, SUITE 200 DUBLIN OH 43017-7550 0 1 0 0 SVP, Chief Compliance Officer Stock Option (Right to Buy) 0.98 2016-02-25 4 A 0 52405 0.00 A 2016-02-26 2026-02-25 Common Stock 52405 52405 D Granted in lieu of cash bonus under 2015 bonus plan. /s/William J. Kelly 2016-02-29